This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Kumamoto University, Nihon Shokuhin Kako Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Hidetoshi Arima: Innovator in Drug Delivery Systems
Introduction
Hidetoshi Arima is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of drug delivery systems, particularly in developing substances that can effectively penetrate the blood-brain barrier. His innovative work has the potential to enhance the treatment of various neurological conditions.
Latest Patents
Hidetoshi Arima holds a patent for a brain-penetrating ligand and drug carrier. This exemplary substance is designed to permeate the blood-brain barrier, showcasing its ability to penetrate into the brain. The patent also details the use of this substance as a drug carrier for delivering medications directly into the brain. Additionally, it includes a pharmaceutical composition that features lactose-modified cyclodextrin or dendrimer/glucuronyl glucosyl-cyclodextrin, both of which are capable of crossing the blood-brain barrier. This innovative approach aims to improve the efficacy of drug delivery for neurological therapies.
Career Highlights
Throughout his career, Hidetoshi Arima has worked with prominent organizations, including Nihon Shokuhin Kako Co., Ltd. and Kumamoto University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in drug delivery systems.
Collaborations
Hidetoshi Arima has collaborated with notable colleagues such as Taishi Higashi and Keiichi Motoyama. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the pharmaceutical industry.
Conclusion
Hidetoshi Arima's work in creating substances that can effectively penetrate the blood-brain barrier represents a significant advancement in drug delivery systems. His innovative patent and collaborations highlight his commitment to improving medical treatments for neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile